Source: Annual Congress 2011 - Obesity and the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. O'Donnell (Kingston, Canada). When obesity and COPD collide: physiological and clinical consequences. Annual Congress 2011 - Obesity and the lung

Member's Comments

No comment yet.

Related content which might interest you: The future of COPD treatment: what are the difficulties in and barriers to drug development for COPD Source: Annual Congress 2011 - Lancet / ERS symposium - New frontiers in COPD Year: 2011 Do childhood factors and asthma modify the impact of smoking on COPD? Source: Annual Congress 2010 - Risk factors for asthma in children and adults including severe disease Year: 2010 Understanding the pathophysiological mechanisms of cardiometabolic complications in obstructive sleep apnoea: towards personalised treatment approaches Source: Eur Respir J, 56 (2) 1902295; 10.1183/13993003.02295-2019 Year: 2020 Disturbed sleep and breathing disturbances in COPD and restrictive lung diseases: evidence gaps and challenges in diagnosis and treatment Source: 5th Sleep and Breathing Conference Year: 2019 Understanding the impact of physical activity in COPD outcomes: moving forward Source: Eur Respir J 2014; 44: 1107-1109 Year: 2014 Metabolic consequences of obesity as an “outside in” mechanism of disease severity in asthma Source: Eur Respir J 2016; 48: 291-293 Year: 2016 Facing the challenges of self-management in COPD: how do people adapt to the disease, its symptoms and resulting limitations? Source: Eur Respir J 2005; 26: Suppl. 49, 310s Year: 2005 The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories Source: Eur Respir J, 58 (5) 2004656; 10.1183/13993003.04656-2020 Year: 2021 Fructosamine-3-Kinase: A molecular link between COPD and diabetes regulating carbonyl stress and the impact of metformin treatment Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Molecular and cytological features of occupational chronic obstructive pulmonary disease in subjects exposed to different environmental factors Source: International Congress 2015 – Occupational factors in COPD and bronchitis Year: 2015 The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases Source: International Congress 2014 – Markers Year: 2014 Mechanisms in asthma and COPD: different but increasingly similar Source: Annual Congress 2010 - Similarities and differences between asthma and COPD: the "Dutch Hypothesis" revisited Year: 2010 Unravelling associations between fatigue and key outcomes in patients with COPD Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease Year: 2020 Dynapenia in COPD exacerbation: what is its relevance in clinical prognosis? Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy Year: 2017 Defining “stable chronic hypercapnia” in patients with COPD: the physiological perspective Source: Eur Respir J, 55 (2) 1902172; 10.1183/13993003.02172-2019 Year: 2020 Defining “stable chronic hypercapnia” in patients with COPD: the physiological perspective Source: Eur Respir J, 55 (2) 1902365; 10.1183/13993003.02365-2019 Year: 2020 Smoking cessation: key for both COPD and cardiovascular disease, but how to manage it? Source: International Congress 2017 – COPD and comorbid cardiovascular diseases Year: 2017 Gender differences in cardiorespiratory dynamics in the coexistence of OSA and COPD Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea Year: 2016